Free Trial

TScan Therapeutics (TCRX) Insider Trading & Ownership

TScan Therapeutics logo
$1.10 -0.07 (-5.60%)
As of 03:49 PM Eastern
This is a fair market value price provided by Massive. Learn more.

TScan Therapeutics (NASDAQ:TCRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.25%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$3.25M
Number Of
Insiders Selling
(Last 12 Months)
0
Get TCRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling TScan Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TCRX Insider Buying and Selling by Quarter

TScan Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/23/2025
Lynx1 Capital Management Lp
Major Shareholder
Buy6,232$0.90$5,608.80  
12/22/2025
Lynx1 Capital Management Lp
Major Shareholder
Buy75,500$0.90$67,950.00  
12/19/2025
Lynx1 Capital Management Lp
Major Shareholder
Buy80,069$0.90$72,062.10  
5/20/2025
Lynx1 Capital Management Lp
Major Shareholder
Buy1,200,000$1.20$1,440,000.00  
5/19/2025
Lynx1 Capital Management Lp
Major Shareholder
Buy1,388,794$1.20$1,666,552.80  
(Data available from 1/1/2013 forward)

TCRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at TScan Therapeutics includes Barbara Klencke, Lynx1 Capital Management Lp, Timothy J Barberich, and Zoran Zdraveski. Learn more on insiders at TCRX.

6.25% of TScan Therapeutics stock is owned by insiders. Learn more on TCRX's insider holdings.

The following insiders have purchased TCRX shares in the last 24 months: Barbara Klencke ($82,550.00), and Lynx1 Capital Management Lp ($3,256,283.68).

Insiders have purchased a total of 2,766,542 TCRX shares in the last 24 months for a total of $3,338,833.68 bought.

The following insider sold TCRX shares in the last 24 months: Zoran Zdraveski ($951,885.08).

Insiders have sold a total of 164,686 TScan Therapeutics shares in the last 24 months for a total of $951,885.08 sold.



This page (NASDAQ:TCRX) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners